ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Mashelkar Report on IP Rights Version II: Wrong Again

The fi rst report of the Mashelkar Committee on patent issues was accused of plagiarism and the committee was asked by the government to rexamine its recommendations. The second report of this committee poses a different set of problems. This article argues that the revised recommendations are not warranted by the TRIPs agreement of the World Trade Organisation, that they are not supported by the weight of academic opinion and that the conclusions do not rest on any reasonable assessment of national interest in pharmaceutical policy.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top